Folic acid supplementation mitigates risk of neural tube defects linked to HIV drug

Dolutegravir is a preferred medication for treating HIV infection, but it recently has been linked to a 6- to 9-fold increase in the risk for neural tube defects among babies born to mothers receiving the drug during early gestation.

From http://besthealthnews.com/2019/07/folic-acid-supplementation-mitigates-risk-of-neural-tube-defects-linked-to-hiv-drug/?utm_source=rss&utm_medium=rss&utm_campaign=folic-acid-supplementation-mitigates-risk-of-neural-tube-defects-linked-to-hiv-drug

from
https://healthnews010.wordpress.com/2019/07/24/folic-acid-supplementation-mitigates-risk-of-neural-tube-defects-linked-to-hiv-drug/

From https://jamesjohnson10.blogspot.com/2019/07/folic-acid-supplementation-mitigates.html

from
https://jamesjohnson10.wordpress.com/2019/07/24/folic-acid-supplementation-mitigates-risk-of-neural-tube-defects-linked-to-hiv-drug/

From https://judywright2.blogspot.com/2019/07/folic-acid-supplementation-mitigates.html

from
https://judywright2.wordpress.com/2019/07/24/folic-acid-supplementation-mitigates-risk-of-neural-tube-defects-linked-to-hiv-drug/